Bioniq, a pioneer in personalized supplements based on blood biomarker analysis, today announced that it has entered into an agreement for the sale of its assets to Herbalife Ltd., the number one active and lifestyle nutrition brand in the world.<\/p>\n
The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals. The $55 million purchase price will be paid over five years, including an initial payment of $10 million at closing. In addition, the transaction value includes up to $95 million of contingent payments based on future performance.<\/p>\n
Vadim Fedotov, Founder of Bioniq, will join Herbalife\u2019s leadership team following the completion of the transaction. Key members of the Bioniq team will also transition to Herbalife.<\/p>\n
Scaling Personalized Nutrition Globally<\/strong><\/p>\n The acquisition will enable Bioniq\u2019s science-driven, personalized supplementation platform to scale globally through Herbalife\u2019s extensive infrastructure, which spans 95 markets, with over 2 million distributors and millions of customers worldwide.<\/p>\n Bioniq\u2019s proprietary algorithm, formulation capabilities, and international team will be integrated into Herbalife\u2019s ecosystem, accelerating product innovation, expanding access, and enhancing the customer experience globally.<\/p>\n A Data-Driven Approach to Health<\/strong><\/p>\n Founded in 2019, Bioniq develops personalized supplement formulas using its patented product personalization engine, an individual\u2019s health background, and a proprietary database of biomarkers. Bioniq\u2019s personalized supplement formulations are designed for a broad range of individuals, from everyday wellness consumers to elite athletes, including Cristiano Ronaldo.<\/p>\n Bioniq has built one of the largest proprietary datasets in the category, comprising over 6 million data points collected across five continents. Its patented algorithm identifies micronutrient imbalances and delivers precision daily nutrient support, complemented by one-on-one consultations and ongoing health insights.<\/p>\n Headquartered in London, Bioniq serves customers in more than 70 markets worldwide, including the United States, Europe, and the Middle East.<\/p>\n The Company is backed by prominent investors, including HV Capital and Unbound, as well as elite athletes Cristiano Ronaldo and Diogo Dalot.<\/p>\n